New rounds of cuts and organizational shifts for HHS staff and operating divisions could dramatically impact the healthcare and life sciences industry....more
Dr. Martin Makary has been confirmed by the Senate as the next commissioner of the Food and Drug Administration (FDA). Dr. Makary is taking the helm at FDA during an unprecedented time for the agency, which has been subject...more
On Feb. 4, 2025, Virginia Speaker of the House Don Scott announced the creation of short-term emergency committee to address federal program cuts and layoffs. On March 8, 2025, Senate Finance and Appropriations Chairwoman...more
The administration continues to advance its agenda via executive orders amid confusion around rollbacks and rescissions. Last week, the Trump administration continued to sign several new executive orders imposing and...more
President Donald Trump addressed a joint session of Congress on March 4; the first such speech of a presidency is not considered a “State of the Union” address, though it shares the same format and function. At an hour and 40...more
Editor’s Note: PYA and Foley & Lardner hosted the 7th Annual “Let’s Talk Compliance” two-day virtual conference on January 23 and 24, 2025. Panelists included Foley attorneys and PYA subject matter experts. The event was...more
The administration also turned its focus to copper imports, bird flu, and a proposed new path to American citizenship....more
In the health policy world, nothing gets folks like me more “excited” than expecting and then seeing a new healthcare regulation pop up in the Federal Register. While the content of the reg is usually what public stakeholders...more
Holland & Knight Health Dose Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector....more